Answers are grounded in this paper and cite their sources.
These outcomes confirm the clinical safety, performance, and benefit of an innovative active transcutaneous bone conduction implant using a piezoelectric transducer design in subjects with conductive hearing loss, mixed hearing loss, or single-sided sensorineural deafness.
No takes yet. Share an insight, caveat, or question.
Briggs et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: